HypertensionArchives
Antihypertensive drugs for hyperuricemia in patients with hypertension: a systematic review and network meta-analysis of Chinese trials
Hypertension 5 min.
According to the 2015 China Health and Nutrition Survey, the prevalence of hypertension in China was 27.9%, compared to a global prevalence of 31.1% among adults. Substantial and growing disparities in hypertension rates have been observed across different countries [1, 2]. Hypertension is commonly associated...
Ten-year survival, trends and risk stratification of newly diagnosed idiopathic pulmonary arterial hypertension in China: insights from a national multicenter prospective registry
Hypertension 6 min.
Idiopathic pulmonary arterial hypertension (IPAH) is a progressive and devastating disease. The long-term prognosis of this chronic and lifelong disease is of great concern. In recent decades, improved survival of IPAH was observed in worldwide pulmonary hypertension registries [1, 2, 3, 4–5]....
Network meta analysis of contributions by different healthcare practitioners in digital self care for hypertension
Hypertension 10 min.
Hypertension is one of the prevalent risk factors for cardiovascular diseases, functional impairment, and premature deaths, leading to markedly rising healthcare costs around the world1, 2–3. Multiple hypertension management protocols encourage patient self-care, and where appropriate the engagement...
Immunosuppressive Therapy for Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases: Insights from Japanese Registry
Hypertension 4 min.
Pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) falls under group 1 in the clinical classification of pulmonary hypertension (PH) [1]. Between 2016 and 2020, CTD-PAH accounted for 32.4% of registered cases in the Japanese registry, making it the second most...
